BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3855478)

  • 1. Prostaglandin E2 production by EL 4 leukemia cells from C57BL/6 mice: mechanism for tumor dissemination.
    Mahan M; Meunier J; Newby M; Young MR
    J Natl Cancer Inst; 1985 Jan; 74(1):191-5. PubMed ID: 3855478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prostaglandin E2-producing nonmetastatic Lewis lung carcinoma cells on the migration of prostaglandin E2-responsive metastatic Lewis lung carcinoma cells.
    Young MR; Young ME; Wepsic HT
    Cancer Res; 1987 Jul; 47(14):3679-83. PubMed ID: 3109729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between morphology, dissemination, migration, and prostaglandin E2 secretion by cloned variants of Lewis lung carcinoma.
    Young MR; Newby M; Meunier J
    Cancer Res; 1985 Aug; 45(8):3918-23. PubMed ID: 3860290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E production by Lewis lung carcinoma: mechanism for tumor establishment in vivo.
    Young MR; Knies S
    J Natl Cancer Inst; 1984 Apr; 72(4):919-22. PubMed ID: 6584667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of a functional prostaglandin E2-protein kinase A coupling with responsiveness of metastatic Lewis lung carcinoma variants to prostaglandin E2 and to prostaglandin E2-producing nonmetastatic Lewis lung carcinoma variants.
    Young MR; Duffie GP; Lozano Y; Young ME; Wright MA
    Cancer Res; 1990 May; 50(10):2973-8. PubMed ID: 2159367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of Lewis lung carcinoma cell migration by prostaglandin E2 produced by macrophages.
    Young MR; Newby M
    Cancer Res; 1986 Jan; 46(1):160-4. PubMed ID: 3455665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro locomotion of allosensitized T lymphocyte clones in response to metabolites of arachidonic acid is subset specific.
    Jordan ML; Hoffman RA; Debe EF; Simmons RL
    J Immunol; 1986 Jul; 137(2):661-8. PubMed ID: 3013998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of increased tumor cell responsiveness to prostaglandin E2 with more aggressive tumor behavior.
    Young MR; Okada F; Tada M; Hosokawa M; Kobayashi H
    Invasion Metastasis; 1991; 11(1):48-57. PubMed ID: 2061004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of spleen cell cytotoxic capacity toward tumor by elevated prostaglandin E2 levels in mice bearing Lewis lung carcinoma.
    Young MR; Hoover CS
    J Natl Cancer Inst; 1986 Aug; 77(2):425-9. PubMed ID: 2942724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E2 regulation of tumoristatic factor production by macrophage-like P388D1 cells.
    Young MR; Simmermaker JA
    J Natl Cancer Inst; 1984 Oct; 73(4):959-62. PubMed ID: 6592390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosubversive role of PGE2 in tumor bearing mice.
    Ippoliti F; Sezzi ML; Bellelli L; Naso G; Pontieri GM
    Boll Ist Sieroter Milan; 1985; 64(1):25-34. PubMed ID: 3859302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the prostaglandin E2 receptor in mammary tumor metastasis.
    Fulton AM; Zhang SZ; Chong YC
    Cancer Res; 1991 Apr; 51(8):2047-50. PubMed ID: 1849040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of prostaglandin E2 by tumor cells in vitro.
    Owen K; Gomolka D; Droller MJ
    Cancer Res; 1980 Sep; 40(9):3167-71. PubMed ID: 7427935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential responsiveness of murine T lymphomas to local growth and invasion factors may determine metastasis formation in the ovaries.
    Schmidt C; Laporte A; De Baetselier P
    Invasion Metastasis; 1997; 17(2):53-61. PubMed ID: 9561024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulatory effect of epidermal growth factor on prostaglandin E2 production in mouse fibrosarcoma cell line (HSDM1 C1).
    Hirata Y; Uchihashi M; Nakashima H; Fujita T; Matsukura S
    Horm Metab Res; 1985 Sep; 17(9):448-50. PubMed ID: 2995220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance of corneal endothelial cell shape by prostaglandin E2: effects of EGF and indomethacin.
    Neufeld AH; Jumblatt MM; Matkin ED; Raymond GM
    Invest Ophthalmol Vis Sci; 1986 Oct; 27(10):1437-42. PubMed ID: 3489692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibition of the growth of a murine transplantable tumor, colon 26, by the prostaglandin synthetase inhibitor, indomethacin].
    Takahashi M; Narisawa T; Masuda T; Nagasawa O; Suzuki K; Yoshioka H; Koyama H
    Gan To Kagaku Ryoho; 1987 Jul; 14(7):2334-40. PubMed ID: 3111384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythromyeloid tumor cells (K562) induce PGE synthesis in human peripheral blood monocytes.
    Leung KH; Fischer DG; Koren HS
    J Immunol; 1983 Jul; 131(1):445-9. PubMed ID: 6575096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
    Zweifel BS; Davis TW; Ornberg RL; Masferrer JL
    Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor production by rat Kupffer cells-regulation by lipopolysaccharide, macrophage activating factor and prostaglandin E2.
    Tanaka M; Ishibashi H; Hirata Y; Miki K; Kudo J; Niho Y
    J Clin Lab Immunol; 1996; 48(1):17-31. PubMed ID: 10332631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.